Toru Maruyama is an experienced scientist specializing in bioinformatics and data science, with a robust background in cancer immunology research. At Roche, from September 2020 to June 2022, Maruyama served as a Principal Scientist and Data Scientist. Currently, within Chugai Pharmaceutical Co., Ltd. since April 2018, Maruyama focuses on leading translational research and collaborating with the National Cancer Center Japan on cancer immunology projects utilizing patient-derived multi-omics data. Previously, Maruyama gained experience as a Research Fellow at the Japan Society for the Promotion of Science from April 2016 to March 2018, and completed a research internship at the Eisai Research Institute in mid-2016. Educational credentials include a Doctor of Engineering and a Master of Engineering in Bioinformatics from Waseda University, obtained in 2018 and 2014, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices